sever
acut
respiratori
syndrom
sar
newli
emerg
infecti
diseas
potenti
recurr
diseas
anim
reservoir
highlight
signific
develop
safe
effici
vaccin
prevent
futur
sar
epidem
studi
express
recombin
receptorbind
domain
rrbd
mammalian
cell
insect
cell
e
coli
respect
compar
immunogen
protect
sarscov
infect
establish
mous
model
result
show
rrbd
protein
express
system
maintain
intact
conform
abl
induc
highli
potent
neutral
antibodi
respons
complet
protect
immun
sarscov
challeng
mice
albeit
rrbd
express
cell
elicit
stronger
humor
immun
respons
significantli
higher
neutral
activ
p
b
express
e
coli
cell
result
suggest
three
rrbd
effect
elicit
immun
respons
protect
sarscov
express
system
use
product
rrbdbase
sar
subunit
vaccin
prefer
given
rrbd
express
mammalian
cell
futur
evalu
vaccin
efficaci
nonhuman
primat
model
sar
abil
refold
nativ
conform
readili
induc
higher
level
neutral
antibodi
respons
express
e
coli
insect
cell
sever
acut
respiratori
syndrom
sar
novel
emerg
infecti
diseas
first
identifi
late
guangdong
china
zhong
et
al
worldwid
outbreak
diseas
led
hundr
death
among
thousand
total
infect
individu
skowronski
et
al
although
new
case
sar
report
sinc
studi
sar
caus
agent
sar
coronaviru
sarscov
continu
sar
still
safeti
concern
presenc
possibl
anim
reservoir
includ
natur
reservoir
bat
intermedi
host
palm
civet
raccoon
dog
kan
et
al
lau
et
al
li
et
al
therefor
essenti
develop
vaccin
sar
prevent
futur
outbreak
genom
sarscov
encod
four
structur
protein
includ
spike
membran
envelop
e
nucleocapsid
n
nonstructur
protein
marra
et
al
rota
et
al
among
sarscov
protein
protein
play
essenti
role
receptorbind
viru
entri
membran
fusion
tripet
et
al
wong
et
al
xu
et
al
zhu
et
al
sarscov
first
bind
host
cellular
receptor
angiotensinconvert
enzym
dimitrov
kuhn
et
al
li
et
al
prabakaran
et
al
via
receptorbind
domain
rbd
acid
aa
fragment
span
residu
region
babcock
et
al
wong
et
al
xiao
et
al
protein
also
main
domain
induc
neutral
antibodi
sar
thu
consid
main
compon
develop
sar
vaccin
du
et
al
proteinbas
vaccin
may
develop
fulllength
protein
fragment
hu
et
al
zakhartchouk
et
al
variou
vector
encod
protein
includ
dnabas
martin
et
al
wang
et
al
yang
et
al
viral
vectorbas
vaccin
gao
et
al
linig
et
al
proteinbas
vaccin
candid
may
induc
humor
immun
respons
andor
neutral
antibodi
well
cellular
immun
respons
vaccin
anim
hu
et
al
huang
et
al
kobing
et
al
dna
vaccin
encod
protein
induc
neutral
antibodi
cellular
immun
respons
healthi
adult
phase
clinic
trial
martin
et
al
sinc
fulllength
proteinbas
vaccin
might
induc
potenti
harm
immun
respons
czub
et
al
weingartl
et
al
vaccin
base
fragment
protein
rbd
greater
potenti
develop
effect
vaccin
sar
lee
et
al
zhao
et
al
zhou
et
al
previous
show
cellexpress
fusion
protein
rbdfc
contain
rbd
sarscov
fc
fragment
human
igg
elicit
neutral
antibodi
respons
protect
vaccin
anim
du
et
al
et
al
et
al
suggest
potenti
develop
rbdbase
subunit
sar
vaccin
howev
big
molecul
fc
fusion
protein
may
caus
unwant
respons
use
human
sar
vaccin
futur
addit
unknown
whether
insect
cell
e
coli
express
system
suitabl
product
recombin
protein
larg
quantiti
use
express
rrbd
function
although
report
truncat
antigen
fragment
aa
protein
sarscov
express
insect
cell
exhibit
high
specif
sensit
detect
antisarscov
antibodi
sera
sar
patient
lack
crossreact
sera
patient
infecti
bronchiti
viru
ibv
transmiss
gastroenter
viru
tgev
infect
manopo
et
al
studi
express
rrbd
protein
without
fc
three
differ
express
system
includ
mammalian
cell
insect
cell
e
coli
compar
immunogen
protect
mous
model
humor
immun
respons
detect
use
sera
mice
vaccin
rrbd
protein
pb
use
neg
control
reactiv
serum
antibodi
rrbd
rbdspecif
igg
detect
elisa
use
sera
dilut
mice
preimmun
day
vaccin
data
present
mean
standard
error
se
five
mice
per
group
indic
signific
differ
p
b
respect
rbdec
group
b
abil
antibodi
bind
rrbd
detect
elisa
use
serial
dilut
sera
collect
mice
day
postlast
vaccin
data
present
mean
se
five
mice
per
group
variou
dilut
point
rbdec
indic
rrbd
protein
express
e
coli
cell
respect
neutral
antibodi
activ
detect
use
sera
mice
vaccin
rrbd
protein
pb
use
neg
control
sera
collect
day
postlast
vaccin
use
detect
neutral
antibodi
titer
sar
pseudoviru
infect
data
present
se
neutral
antibodi
titer
nt
five
mice
per
group
indic
signific
differ
p
b
group
rbdec
group
b
neutral
antibodi
titer
live
sarscov
infect
titer
determin
highest
dilut
sera
could
complet
prevent
cpe
least
well
nt
present
se
five
mice
per
group
indic
signific
differ
p
b
vaccin
group
group
rrbd
protein
express
mammalian
cell
insect
cell
e
coli
express
system
maintain
intact
conform
authent
antigen
purifi
rrbd
protein
express
express
system
detect
western
blot
use
panel
monoclon
antibodi
mab
contain
differ
conform
linear
epitop
rbd
et
al
shown
fig
rrbd
protein
express
mammalian
cell
insect
cell
e
coli
rbdec
react
major
conform
epitopespecif
mab
one
linear
epitopespecif
mab
strongest
reaction
conf
v
mab
linear
mab
result
suggest
rrbd
protein
express
mammalian
cell
insect
cell
e
coli
maintain
intact
conform
authent
antigen
rrbd
protein
express
cell
induc
higher
level
rbdspecif
antibodi
vaccin
mice
express
e
coli
evalu
humor
immun
respons
induc
rrbd
express
three
differ
system
mice
vaccin
rbdec
respect
sera
test
elisa
rbdspecif
igg
shown
fig
three
rrbd
protein
induc
rbdspecif
igg
antibodi
respons
increas
antibodi
bind
boost
reach
highest
level
last
boost
mean
endpoint
titer
antibodi
sera
collect
day
postlast
boost
mice
immun
significantli
higher
sera
mice
vaccin
rbdec
fig
detect
rbdspecif
antibodi
preimmun
sera
vaccin
mice
mice
inject
pb
control
fig
result
suggest
rrbd
protein
express
mammalian
cell
insect
cell
abl
elicit
stronger
sarscov
rbdspecif
antibodi
respons
express
e
coli
rrbd
induc
highli
potent
neutral
antibodi
respons
albeit
neutral
antibodi
titer
elicit
significantli
higher
induc
rrbd
express
e
coli
cell
assess
whether
induc
igg
antibodi
could
neutral
infect
sarscov
cell
cultur
vitro
sera
day
postlast
boost
detect
neutral
assay
use
pseudotyp
live
sarscov
shown
fig
sera
three
vaccin
group
effect
neutral
infect
sar
pseudoviru
cell
express
receptor
particularli
protein
induc
significantli
higher
titer
neutral
antibodi
two
group
mean
neutral
antibodi
titer
nt
neutral
titer
live
sarscov
infect
vero
cell
also
significantli
higher
vaccin
group
mean
nt
rbdec
vaccin
group
fig
neutral
activ
detect
pb
control
group
fig
result
suggest
rrbd
protein
express
mammalian
insect
e
coli
cell
abl
induc
potent
neutral
antibodi
respons
vaccin
mice
evalu
efficaci
protect
immun
induc
rrbd
protein
vaccin
mice
challeng
sarscov
viru
replic
detect
titrat
infecti
viru
mous
lung
tissu
shown
fig
mice
three
individu
rrbd
vaccin
group
could
complet
protect
sarscov
challeng
viru
titer
detect
limit
log
tissuecultur
infecti
dose
tcid
g
lung
tissu
howev
five
mice
pb
control
group
maintain
high
titer
viru
replic
lung
tissu
post
sarscov
challeng
viru
titer
highli
detect
limit
result
suggest
rrbd
protein
elicit
protect
immun
suffici
requir
prevent
vaccin
mice
subsequ
viru
challeng
rrbd
proteinvaccin
mice
sacrif
day
postchalleng
sarscov
mous
lung
tissu
collect
investig
protect
viral
load
lung
tissu
determin
quantit
reversetranscriptas
polymeras
chain
reaction
qrtpcr
indic
viral
rna
lung
tissu
shown
tabl
rna
copi
detect
mice
vaccin
rbdec
respect
high
level
rna
copi
detect
lung
tissu
control
mice
administr
pb
suppress
viru
replic
lung
tissu
may
associ
high
titer
virusneutr
antibodi
induc
three
rrbd
protein
high
fig
protect
immun
detect
mice
vaccin
rrbd
protein
mice
respect
vaccin
rbdec
challeng
sarscov
sarscov
replic
challeng
mous
lung
tissu
detect
express
log
tcid
g
tissu
indic
five
mice
per
group
limit
detect
log
tcid
g
lung
tissu
tabl
measur
sarscov
rna
copi
lung
tissu
qrtpcr
potenti
correl
rna
copi
neutral
antibodi
titer
neutral
level
rna
copi
lung
tissu
pb
control
mice
may
attribut
undetect
neutral
antibodi
respons
mice
tabl
main
purpos
studi
determin
whether
rrbd
without
human
igg
fc
could
induc
effect
neutral
antibodi
respons
protect
immun
insect
cell
e
coli
express
system
like
mammalian
cell
express
system
also
use
product
function
rbd
shown
fig
rrbd
without
fc
express
mammalian
cell
insect
cell
e
coli
rbdec
abl
react
major
panel
mab
recogn
differ
conform
linear
epitop
rbd
sarscov
protein
except
mab
conf
iii
mab
gener
immun
recombin
rbdfc
fusion
protein
character
recogn
specif
conform
epitop
present
rbd
fuse
fc
fragment
human
igg
suggest
epitop
may
present
rrbd
independ
express
current
express
three
rrbd
protein
without
fc
could
obtain
puriti
data
shown
addit
three
rrbd
protein
elicit
strong
rbdspecif
antibodi
respons
vaccin
mice
albeit
titer
antibodi
induc
significantli
higher
rbdec
fig
result
suggest
three
rbd
protein
retain
proper
immunogen
rbd
express
e
coli
less
immunogen
express
mammalian
insect
cell
similarli
three
rrbd
protein
elicit
high
titer
neutral
antibodi
neutral
sar
pseudoviru
live
sarscov
infect
cell
cultur
vitro
although
titer
neutral
antibodi
induc
higher
rbdec
fig
previou
studi
demonstr
protect
immun
anim
viru
challeng
mediat
humor
tcelldepend
immun
mechan
yang
et
al
also
evalu
protect
immun
vaccin
mice
sarscov
challeng
found
rrbd
protein
express
mammalian
insect
e
coli
cell
could
induc
equal
protect
immun
protect
vaccin
mice
sarscov
challeng
sinc
rna
copi
detect
challeng
mous
lung
tissu
viral
replic
significantli
detect
limit
vaccin
group
fig
tabl
consist
report
yang
et
al
protect
mainli
associ
neutral
antibodi
result
also
agreement
previou
studi
rbdfc
vaccin
du
et
al
present
studi
provid
answer
first
question
role
human
igg
fc
induct
neutral
antibodi
respons
protect
immun
although
fc
fragment
fusion
protein
contain
antigen
inde
significantli
enhanc
immunogen
antigen
increas
product
neutral
antibodi
differ
mechan
eg
assist
antigen
bind
fcr
chen
et
al
prolong
vivo
halflif
antigen
zhang
et
al
fc
seem
play
critic
role
enhanc
immunogen
rrbd
sarscov
absenc
fc
rrbd
express
cell
elicit
similar
level
neutral
antibodi
respons
protect
immun
vaccin
anim
rbdfc
express
cell
second
question
need
answer
whether
insect
cell
e
coli
express
system
suitabl
produc
function
rrbd
vaccin
larg
quantiti
product
recombin
proteinbas
vaccin
insect
cell
e
coli
express
system
superior
mammalian
cell
express
system
insect
cell
e
coli
grow
high
densiti
room
temperatur
without
suppli
co
express
recombin
protein
fast
easi
reliabl
way
result
lower
product
cost
higher
protein
product
mammalian
express
system
boosani
sudhakar
farinhaarcieri
et
al
marbleston
et
al
saitoh
et
al
although
rrbd
express
mammalian
cell
induc
stronger
rbdspecif
antibodi
respons
higher
titer
neutral
antibodi
express
insect
cell
e
coli
express
system
rbdec
also
maintain
intact
conform
elicit
neutral
antibodi
respons
strong
enough
protect
vaccin
host
sarscov
challeng
fig
tabl
previou
studi
also
demonstr
rrbdimmun
age
mice
serum
neutral
antibodi
titer
rang
detect
sarscov
lung
viru
challeng
margin
level
sarscov
replic
detect
one
mice
serum
neutral
antibodi
titer
du
et
al
group
report
mice
immun
attenu
viru
dna
vaccin
encod
sarscov
protein
inactiv
viru
serum
neutral
antibodi
titer
rang
mice
protect
sarscov
challeng
bisht
et
al
stadler
et
al
yang
et
al
three
patient
fail
respond
avail
treatment
recov
seriou
sar
transfus
sar
convalesc
plasma
neutral
titer
n
yeh
et
al
base
data
suggest
vaccin
induc
immun
mice
serum
neutral
antibodi
titer
would
consid
highli
effect
accord
criteria
believ
either
insect
cell
e
coli
express
system
use
product
rbdbase
sar
subunit
vaccin
larg
scale
rbdec
could
induc
high
titer
mean
valu
n
neutral
antibodi
strong
protect
immun
protect
vaccin
mice
sarscov
challeng
compar
insect
cell
e
coli
express
system
mammalian
cell
system
rel
higher
product
cost
lower
product
main
advantag
mammalian
cell
system
two
express
system
far
higher
chanc
get
correctli
fold
solubl
protein
proper
glycosyl
make
express
protein
maintain
nativ
conform
keep
suffici
bioactiv
du
et
al
yin
et
al
advantag
may
partial
explain
express
mammalian
cell
induc
stronger
immun
respons
particularli
neutral
antibodi
respons
rrbd
protein
express
insect
cell
e
coli
fig
summar
comprehens
studi
compar
immun
respons
protect
immun
three
sar
subunit
vaccin
base
rrbd
protein
respect
express
mammalian
cell
insect
cell
e
coli
absenc
human
igg
fc
rrbd
express
three
express
system
effect
elicit
potent
neutral
antibodi
respons
protect
immun
consid
rrbd
protein
express
mammalian
cell
induc
significantli
higher
level
neutral
antibodi
respons
express
insect
cell
e
coli
select
mammalian
cellexpress
rrbd
protein
evalu
vivo
efficaci
nonhuman
primat
model
sar
go
clinic
trial
gene
encod
fragment
contain
residu
aa
sarscov
protein
rbd
tag
amplifi
pcr
use
plasmid
contain
fulllength
protein
strain
templat
du
et
al
et
al
construct
recombin
plasmid
name
rrbdsumo
rrbdbacul
respect
express
rrbd
protein
pet
sumo
e
coli
system
rbdec
done
follow
manufactur
protocol
invitrogen
carlsbad
ca
briefli
rrbdsumo
e
coli
cultur
lb
medium
overnight
dilut
next
day
cultur
vigor
shake
od
reach
iptg
sigma
st
loui
mo
ad
final
concentr
mm
follow
cultur
addit
h
centrifug
rpm
min
sonic
e
coli
supernat
contain
express
rrbd
protein
collect
purifi
use
column
promega
madison
wi
accord
manufactur
protocol
express
rrbd
protein
baculoviru
system
conduct
accord
manufactur
protocol
bd
bioscienc
san
jose
ca
brief
rrbdbacul
plasmid
mix
bd
baculogold
linear
baculoviru
dna
sat
min
room
temperatur
ad
ml
bd
baculogold
transfect
buffer
b
mixtur
ad
dropwis
insect
cell
atcc
manassa
va
precov
ml
transfect
buffer
follow
incub
cell
h
cultur
transfect
cell
fresh
ii
sfm
invitrogen
addit
day
supernat
collect
day
later
use
infect
cell
three
cultur
cycl
viru
amplif
cell
cultur
supernat
cycl
collect
purif
rrbd
protein
transient
express
rrbd
protein
vector
perform
accord
manufactur
invitrogen
previou
protocol
du
et
al
briefli
plasmid
transfect
use
calcium
phosphat
method
cell
atcc
cultur
medium
replac
fresh
optimem
reducedserum
medium
invitrogen
h
later
supernat
contain
express
rrbd
protein
collect
h
later
purifi
rrbd
protein
purifi
rrbd
protein
detect
sodium
dodecyl
sulfatepolyacrylamid
gel
electrophoresi
sdspage
western
blot
describ
du
et
al
briefli
purifi
protein
separ
tricin
gel
invitrogen
transfer
nitrocellulos
membran
biorad
laboratori
hercul
ca
block
overnight
blot
incub
panel
rbdspecif
mab
previous
produc
laboratori
et
al
final
concentr
h
room
temperatur
blot
incub
horseradish
peroxidas
hrp
conjug
goat
antimous
igg
zyme
carlsbad
ca
h
room
temperatur
signal
visual
ecl
western
blot
substrat
reagent
amersham
hyperfilm
ge
healthcar
piscataway
nj
group
five
femal
balbc
mice
age
week
vaccin
subcutan
sc
purifi
rrbd
protein
resuspend
pb
presenc
sigma
adjuv
system
sa
sigma
boost
twice
immunogen
contain
sa
interv
serum
sampl
collect
day
posteach
vaccin
use
detect
igg
neutral
antibodi
respons
vaccin
mice
challeng
live
sarscov
day
postlast
vaccin
viral
replic
detect
challeng
mous
lung
day
postchalleng
mous
studi
maintain
accord
nation
anim
care
protocol
igg
specif
rbd
sarscov
protein
mous
sera
test
elisa
use
protocol
describ
previous
du
et
al
modif
briefli
microtit
plate
precoat
respect
recombin
rrbd
protein
overnight
block
nonfat
milk
h
serial
dilut
mous
sera
ad
plate
incub
h
follow
four
wash
bound
antibodi
react
hrpconjug
goat
antimous
igg
h
four
wash
substrat
tmb
zyme
ad
plate
reaction
stop
ad
n
h
absorb
nm
measur
elisa
plate
reader
tecan
san
jose
ca
neutral
assay
sar
pseudoviru
infect
done
previous
describ
briefli
cell
cotransfect
plasmid
encod
sarscov
protein
plasmid
encod
envdefect
luciferaseexpress
genom
use
fugen
transfect
reagent
roch
appli
scienc
supernat
harvest
h
posttransfect
use
singlecycl
infect
cell
pseudoviruscontain
supernat
preincub
serial
dilut
mous
sera
h
ad
cell
fresh
medium
ad
h
later
follow
lyse
cell
use
cell
lysi
buffer
promega
addit
luciferas
substrat
promega
rel
luciferas
activ
determin
ultra
luminomet
tecan
sar
pseudoviru
neutral
calcul
express
neutral
antibodi
titer
nt
chou
neutral
assay
infect
live
sarscov
strain
genbank
access
perform
titer
neutral
antibodi
vaccin
mous
sera
detect
vero
cell
atcc
previous
describ
du
et
al
du
et
al
briefli
serial
dilut
sera
mix
tcid
sarscov
incub
h
ad
monolay
vero
cell
triplic
cytopath
effect
cpe
well
observ
daili
record
day
postinfect
neutral
titer
mous
antisera
complet
prevent
cpe
well
nt
calcul
du
et
al
du
et
al
rrbd
proteinvaccin
mice
anesthet
isofluran
intranas
inocul
sarscov
tcid
accord
nation
anim
care
use
guidelin
approv
anim
laboratori
mice
sacrif
day
viru
challeng
lung
remov
virolog
test
viral
rna
copi
lung
tissu
determin
qrtpcr
accord
previou
protocol
du
et
al
briefli
total
rna
extract
mg
lung
tissu
use
rneasi
mini
kit
qiagen
valencia
ca
sarscov
rna
quantifi
mixtur
contain
rna
taqman
onestep
rtpcr
master
mix
abi
foster
ca
multiscrib
forward
primer
af
cct
cgc
caa
aaa
cgt
revers
primer
ar
tca
gcc
atg
ttc
ccg
probe
cgc
att
ggc
atg
gaa
gtc
aca
cttamra
tib
molbiol
berlin
germani
use
fluorometr
pcr
instrument
abi
viral
replic
determin
titrat
inocul
viru
lung
tissu
previous
describ
du
et
al
briefli
lung
tissu
homogen
final
concentr
wv
suspens
dmem
tissu
homogen
centrifug
filtrat
inocul
monolay
vero
cell
result
evalu
day
later
phasecontrast
microscopi
viral
titer
use
cpebas
tcid
test
calcul
reedmuench
method
total
amount
viru
calcul
multipli
weight
lung
tissu
viral
titer
measur
tissu
homogen
valu
present
mean
standard
error
se
statist
signific
among
differ
vaccin
group
calcul
student
test
use
stata
statist
softwar
p
valu
less
consid
signific
